Long-Term GeneXpert Positivity after Treatment for Pulmonary Tuberculosis

  • Luisa Costantini Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, Switzerland
  • Marco Marando Department of Pneumology, Ente Ospedaliero Cantonale, Lugano, Switzerland
  • Pietro Gianella Department of Pneumology, Ente Ospedaliero Cantonale, Lugano, Switzerland
DOI: https://doi.org/10.12890/2020_001737

Keywords

Tuberculosis, TB, GeneXpert, retested patients, false positives

Abstract

Tuberculosis (TB) is a cause of ill health and death worldwide. Since 2010, the diagnostic process has strongly relied on GeneXpert assays on biological specimens. Xpert MTB/RIF is an automated nucleic acid amplification test (NAAT) for Mycobacterium tuberculosis and rifampicin resistance, endorsed by the World Health Organization and the US Food and Drug Administration. Xpert is used in many countries as the initial diagnostic test for tuberculosis. Nevertheless, the reliability of GeneXpert positive tests in patients with a history of TB is largely unknown, due to possible false-positive results (i.e., GeneXpert-positive but culture-negative patients). We present a case report of a patient with a history of pulmonary TB, who was GeneXpert positive but culture negative on bronchoalveolar lavage 22 months after completion of appropriate antitubercular therapy.

VIEW THE ENTIRE ARTICLE

References

  • World Health Organization. Global Tuberculosis Report 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1 (accessed 16 June 2020).

  • Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005–1015.

  • Luetkemeyer AF, Firnhaber C, Kendall MA. Evaluation of Xpert MTB/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings. Clin Infect Dis 2016;62(9):1081–1088.

  • Theron G, Venter R, Calligaro G, Smith L, Limberis J, Meldau R, et al. Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? Clin Infect Dis 2016;62(8):995–1001.

  • Theron G, Venter R, Smith L, Esmail A, Randall P, Sood V, et al. False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes. J Clin Microbiol 2018;56(3):e01696-17

    • Published: 2020-07-06

    Issue: Vol 7 No 10 (view)

    Section: Articles

    How to cite:
    1.
    Costantini L, Marando M, Gianella P. Long-Term GeneXpert Positivity after Treatment for Pulmonary Tuberculosis. EJCRIM 2020;7 doi:10.12890/2020_001737.